A Study of ATR-101 for the Treatment of Congenital Adrenal Hyperplasia
Clinical trial NCT02804178 · COMPLETED
Trial details
- NCT number
- NCT02804178
- Sponsor
- Millendo Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-18
- Primary completion
- 2017-08-17
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.